The Asia-Pacific genetic testing market is predicted to record a CAGR of 10.49% during the forecast period, 2022-2030, and is set to reach a revenue of $6662.7 million by 2030.

ASIA-PACIFIC GENETIC TESTING MARKET FORECAST 2022-2030

Asia-Pacific Genetic Testing Market by Type (Prenatal and Newborn Testing, Diagnostic Testing, Predictive & Pre symptomatic Testing, Carrier Testing, Pharmacogenomic Testing, Other Types) Market by Technology (Molecular Testing, Cytogenetic Testing, Biochemical Testing) Market by Application (Genetic Disease Diagnosis, Cancer Diagnosis, Cardiovascular Disease Diagnosis, Other Applications) Market by Disease (Cancer, Cystic Fibrosis, Huntington’s Disease, Sickle Cell Anaemia, Duchenne Muscular Dystrophy, Alzheimer’s Disease, Rare Diseases, Thalassemia, Other Diseases) by Geography

Request free sample

The Asia-Pacific genetic testing market is predicted to record a CAGR of 10.49% during the forecast period, 2022-2030, and is set to reach a revenue of $6662.7 million by 2030.

Asia-Pacific is a densely populated region in the world. This enables a large pool of potential patients for genetic testing. Also, the region witnesses a high growth rate globally in terms of newborn babies. In addition, several developed economies of the region, like Taiwan, South Korea, Singapore, Japan, and China, have advanced medical facilities.

Asia-Pacific Genetic Testing Market

To know more about this report, request a free sample copy

The Asia-Pacific genetic testing market growth assessment includes the analysis of South Korea, Indonesia, Australia & New Zealand, Singapore, Japan, China, Taiwan, India, and Rest of Asia-Pacific. China is the second-largest economy globally with innovative technologies. Also, public healthcare has drastically improved in the last 30 years. At present, it is easily accessible and largely public. However, the country faces many emerging public health challenges like respiratory disorders, given the rising air pollution and unbalanced distribution and development of public health care facilities. Additionally, the government initiatives like listing genetic testing as part of the National Development and Reform Commission in the 13th Five-Year-Plan’s strategy with regard to the biological industry benefit market growth.

Further, several companies in China offer genetic tests directly to consumers. For instance, Genebox provides tests at low costs. Moreover, over 2.2 million Chinese sent test tubes of spit to private companies for their DNA analysis, according to 2019 stats.

In South Korea, genomic medicine is a key domain. Also, precision medicine, genetic testing, direct-to-consumer genetic testing, precision medicine, and genomic research are significantly prioritized in government policies. South Korea has one of the largest biobanks globally. Besides, genetic testing is on the rise for hereditary diseases and cancer diagnoses for personalized treatment. Although a regulatory framework is in place for these tests, quality assurance and health coverage are not in line with the existing demands from clinicians and patients. Furthermore, telecommunications companies and DTC (direct-to-consumer) genetic testing organizations are partnering to help consumers stay informed about their health status. This is done by sending lab results directly to their mobile devices.

The segmentation analysis of the Asia-Pacific genetic testing market includes disease, application, technology, and type. The technology category is further sub-segmented into biochemical testing, cytogenetic testing, and molecular testing. Cytogenetic Testing is an emerging application in terms of revenue share and CAGR.

Cytogenetics is the study of the relationship between genetic diseases and chromosomal aberrations in human beings. It extends beyond the simple description of a genome’s chromosomal status. It further enables the study of fundamental biological questions like the three-dimensional organization of the human genomes, genomic changes in tumorigenesis, and the nature of inherited syndromes. Also, it examines the abnormal and normal chromosomes in relation to disease. Besides, cytogenetic tests are used to acquire prognostic and diagnostic insights into malignancies and solid tumor cancers. This is because these can be a result of altered chromosome numbers.

Some of the key firms in the Asia-Pacific genetic testing market include ELITech Group, Decode Genetics, BGI Group, Eurofins Scientific, etc.

BGI Genomics offers sequencing services and a portfolio of genetic tests for research institutions, public & private partners, and medical institutions. It provides RNA, DNA, and customized sequencing services, clinical exome sequencing services, newborn genetic screening, etc. Also, it offers services in varied research areas like food science & agriculture, metagenomics, drug discovery, biomarker discovery, reproductive health, cancer research, and metagenomics. Moreover, the company’s major operations are in China, with headquarters in Shenzhen, China.

The company offers BGI SENTIS™ Lung Cancer Panel that utilizes genomics to advance precision medicine for cancer. Also, the BGI’s next-generation sequencing assays offer different options, including targeted panels for analyzing genes linked to specific cancers.

Report Synopsis

Report Scope Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed Disease, Application, Technology, Type
Countries Analyzed South Korea, Indonesia, Australia & New Zealand, Singapore, Japan, China, Taiwan, India, and Rest of Asia-Pacific
Companies Analyzed

23&Me Inc, Abbott Laboratories, BGI Group, Bio-Rad Laboratories, CSL Limited, Decode Genetics, ELITech Group, Eurofins Scientific, Illumina Inc, Luminex Corporation, Myriad Genetics Inc, PerkinElmer Inc, Qiagen, Quest Diagnostics Inc, and Roche Diagnostics Inc

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • ADVANCEMENTS IN BIOTECHNOLOGY
        • GROWTH IN PRENATAL TESTING
        • RISE IN DIRECT-TO-CONSUMER GENETIC TESTING
        • GENETIC TESTING HELPS IN DETERMINING MEDICATION DOSAGE
      • KEY RESTRAINTS
        • EXPENSIVE COST OF TREATMENT
        • GOVERNMENT REGULATION AND LEGISLATION
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON GENETIC TESTING MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • VALUE CHAIN ANALYSIS
      • KEY BUYING CRITERIA
      • REGULATORY FRAMEWORK
    2. MARKET BY TYPE
      • PRENATAL AND NEWBORN TESTING
      • DIAGNOSTIC TESTING
      • PREDICTIVE & PRESYMPTOMATIC TESTING
      • CARRIER TESTING
      • PHARMACOGENOMIC TESTING
      • OTHER TYPES
    3. MARKET BY TECHNOLOGY
      • MOLECULAR TESTING
      • CYTOGENETIC TESTING
      • BIOCHEMICAL TESTING
    4. MARKET BY APPLICATION
      • GENETIC DISEASE DIAGNOSIS
      • CANCER DIAGNOSIS
      • CARDIOVASCULAR DISEASE DIAGNOSIS
      • OTHER APPLICATIONS
    5. MARKET BY DISEASE
      • CANCER
      • CYSTIC FIBROSIS
      • HUNTINGTON’S DISEASE
      • SICKLE CELL ANAEMIA
      • DUCHENNE MUSCULAR DYSTROPHY
      • ALZHEIMER’S DISEASE
      • RARE DISEASES
      • THALASSEMIA
      • OTHER DISEASES
    6. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • INDONESIA
          • AUSTRALIA & NEW ZEALAND
          • SINGAPORE
          • TAIWAN
          • REST OF ASIA-PACIFIC
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS & DIVESTITURES
      • COMPANY PROFILES
        • 23&ME INC
        • ABBOTT LABORATORIES
        • BGI GROUP
        • BIO-RAD LABORATORIES
        • CSL LIMITED
        • DECODE GENETICS
        • ELITECH GROUP
        • EUROFINS SCIENTIFIC
        • ILLUMINA INC
        • LUMINEX CORPORATION
        • MYRIAD GENETICS INC
        • PERKINELMER INC
        • QIAGEN
        • QUEST DIAGNOSTICS INC
        • ROCHE DIAGNOSTICS INC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – GENETIC TESTING

    TABLE 2: REGULATORY FRAMEWORK

    TABLE 3: ASIA-PACIFIC GENETIC TESTING MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 4: ASIA-PACIFIC GENETIC TESTING MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 5: ASIA-PACIFIC GENETIC TESTING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 6: ASIA-PACIFIC GENETIC TESTING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 7: ASIA-PACIFIC GENETIC TESTING MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 8: ASIA-PACIFIC GENETIC TESTING MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 9: ASIA-PACIFIC GENETIC TESTING MARKET, BY DISEASE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 10: ASIA-PACIFIC GENETIC TESTING MARKET, BY DISEASE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 11: ASIA-PACIFIC GENETIC TESTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 12: ASIA-PACIFIC GENETIC TESTING MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 13: LEADING PLAYERS OPERATING IN ASIA-PACIFIC GENETIC TESTING MARKET

    TABLE 14: LIST OF MERGERS & ACQUISITIONS

    TABLE 15: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 17: LIST OF BUSINESS EXPANSIONS & DIVESTITURES                           

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: VALUE CHAIN ANALYSIS

    FIGURE 6: ASIA-PACIFIC GENETIC TESTING MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021

    FIGURE 7: ASIA-PACIFIC GENETIC TESTING MARKET, BY PRENATAL AND NEWBORN TESTING GENETIC TESTING, 2022-2030 (IN $ MILLION)

    FIGURE 8: ASIA-PACIFIC GENETIC TESTING MARKET, BY DIAGNOSTIC TESTING, 2022-2030 (IN $ MILLION)

    FIGURE 9: ASIA-PACIFIC CARRIER TESTING MARKET, BY CARRIER TESTING, 2022-2030 (IN $ MILLION)

    FIGURE 10: ASIA-PACIFIC GENETIC TESTING MARKET, BY PHARMACOGENOMIC TESTING, 2022-2030 (IN $ MILLION)

    FIGURE 11: ASIA-PACIFIC GENETIC TESTING MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021

    FIGURE 12: ASIA-PACIFIC GENETIC TESTING MARKET, BY MOLECULAR TESTING, 2022-2030 (IN $ MILLION)

    FIGURE 13: ASIA-PACIFIC GENETIC TESTING MARKET, BY CYTOGENETIC TESTING, 2022-2030 (IN $ MILLION)

    FIGURE 14: ASIA-PACIFIC GENETIC TESTING MARKET, BY BIOCHEMICAL TESTING, 2022-2030 (IN $ MILLION)

    FIGURE 15: ASIA-PACIFIC GENETIC TESTING MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021

    FIGURE 16: ASIA-PACIFIC GENETIC TESTING MARKET, BY GENETIC DISEASE DIAGNOSIS, 2022-2030 (IN $ MILLION)

    FIGURE 17: ASIA-PACIFIC GENETIC TESTING MARKET, BY CANCER DIAGNOSIS, 2022-2030 (IN $ MILLION)

    FIGURE 18: ASIA-PACIFIC GENETIC TESTING MARKET, BY CARDIOVASCULAR DISEASES DIAGNOSIS, 2022-2030 (IN $ MILLION)

    FIGURE 19: ASIA-PACIFIC GENETIC TESTING MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)

    FIGURE 20: ASIA-PACIFIC GENETIC TESTING MARKET, GROWTH POTENTIAL, BY DISEASE, IN 2021

    FIGURE 21: ASIA-PACIFIC GENETIC TESTING MARKET, BY CANCER, 2022-2030 (IN $ MILLION)

    FIGURE 22: ASIA-PACIFIC GENETIC TESTING MARKET, BY CYSTIC FIBROSIS, 2022-2030 (IN $ MILLION)

    FIGURE 23: ASIA-PACIFIC GENETIC TESTING MARKET, BY HUNTINGTON’S DISEASE, 2022-2030 (IN $ MILLION)

    FIGURE 24: ASIA-PACIFIC GENETIC TESTING MARKET, SICKLE CELL ANEMIA, 2022-2030 (IN $ MILLION)

    FIGURE 25: ASIA-PACIFIC GENETIC TESTING MARKET, BY DUCHENNE MUSCULAR DYSTROPHY, 2022-2030 (IN $ MILLION)

    FIGURE 26: ASIA-PACIFIC GENETIC TESTING MARKET, BY ALZHEIMER’S DISEASE, 2022-2030 (IN $ MILLION)

    FIGURE 27: ASIA-PACIFIC GENETIC TESTING MARKET, BY RARE DISEASES, 2022-2030 (IN $ MILLION)

    FIGURE 28: ASIA-PACIFIC GENETIC TESTING MARKET, BY THALASSEMIA, 2022-2030 (IN $ MILLION)

    FIGURE 29: ASIA-PACIFIC GENETIC TESTING MARKET, BY OTHER DISEASES, 2022-2030 (IN $ MILLION)

    FIGURE 30: ASIA-PACIFIC GENETIC TESTING MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

    FIGURE 31: CHINA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 32: JAPAN GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 33: INDIA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 34: SOUTH KOREA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 35: INDONESIA GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 36: AUSTRALIA & NEW ZEALAND GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 37: SINGAPORE GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 38: TAIWAN GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 39: REST OF ASIA-PACIFIC GENETIC TESTING MARKET, 2022-2030 (IN $ MILLION)       

    1. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • INDONESIA
          • AUSTRALIA & NEW ZEALAND
          • SINGAPORE
          • TAIWAN
          • REST OF ASIA-PACIFIC
    1. MARKET BY TYPE
      • PRENATAL AND NEWBORN TESTING
      • DIAGNOSTIC TESTING
      • PREDICTIVE & PRESYMPTOMATIC TESTING
      • CARRIER TESTING
      • PHARMACOGENOMIC TESTING
      • OTHER TYPES
    2. MARKET BY TECHNOLOGY
      • MOLECULAR TESTING
      • CYTOGENETIC TESTING
      • BIOCHEMICAL TESTING
    3. MARKET BY APPLICATION
      • GENETIC DISEASE DIAGNOSIS
      • CANCER DIAGNOSIS
      • CARDIOVASCULAR DISEASE DIAGNOSIS
      • OTHER APPLICATIONS
    4. MARKET BY DISEASE
      • CANCER
      • CYSTIC FIBROSIS
      • HUNTINGTON’S DISEASE
      • SICKLE CELL ANAEMIA
      • DUCHENNE MUSCULAR DYSTROPHY
      • ALZHEIMER’S DISEASE
      • RARE DISEASES
      • THALASSEMIA
      • OTHER DISEASES

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type